Alex Fässler
Directeur des opérations chez Targimmune Therapeutics AG
Fortune : 3 M $ au 30/04/2024
Postes actifs de Alex Fässler
Sociétés | Poste | Début | Fin |
---|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Directeur des opérations | - | - |
Historique de carrière de Alex Fässler
Anciens postes connus de Alex Fässler
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01/01/1998 | - |
BACHEM HOLDING AG | Directeur des opérations | 01/01/1998 | - |
Formation de Alex Fässler
Swiss Federal Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Suisse | 4 |
Allemagne | 2 |
Opérationnelle
Chief Operating Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Entreprise privées | 2 |
---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Bourse
- Insiders
- Alex Fässler
- Expérience